NCT02796131View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

April 30, 2012

Conditions

Healthy

Interventions

DRUG

RDX5791

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Ardelyx

INDUSTRY